Reimplantation of cryopreserved ovarian tissue (OT) can successfully restore ovarian function in young cancer patients after gonadotoxic treatment. However, for patients with leukaemia, there is a risk of malignant cell transmission. Our objective was to evaluate minimal disseminated disease in OT from leukaemia patients and test a follicle isolation technique to obtain disease-free follicle suspensions. Cryopreserved OT from 12 leukaemia patients was thawed and analysed by histology and long-term xenografting in immunosuppressed mice. In 10 patients, follicles were isolated from OT, and polymerase chain reaction (PCR) was performed on tissue, digested ovarian suspensions and isolated follicle suspensions to investigate leukaemic cell presence. Mean patient age was 17Á1 years. An average of 3Á2 follicles were isolated per mm² of cortex. Xenografting of OT induced leukaemic masses in 2/12 mice. PCR identified leukaemic cell presence in 66% of OT. Malignant cells were also detected in digested ovarian suspensions. However, none of the follicle samples (>2300 follicles tested) showed any malignant cell presence after washing. This study demonstrates that it is possible to recover large numbers of viable follicles from cryopreserved OT of leukaemia patients. All isolated and washed follicle suspensions tested negative for leukaemic cells, giving leukaemia patients genuine hope of fertility restoration.
Ovarian tissue cryopreservation (OTC) is gaining ground as an established fertility preservation technique before gonadotoxic therapy, more specifically for prepubertal patients and those requiring immediate treatment (Sanchez et al, 2008; Mayerhofer et al, 2010; Donnez et al, 2011 Rosendahl et al, 2011; Macklon et al, 2014 ; Practice Committee of the American Society for Reproductive Medicine 2014). Transplantation of frozenthawed ovarian cortical strips successfully restores endocrine function and fertility in patients , with 60 reported live births to date , and a live birth rate per patient of~29% .
Leukaemia is the most common form of cancer in children and adolescents (Edwards et al, 2013; Ward et al, 2014) , many of whom are prepubertal and require immediate chemotherapy. OTC prior to gonadotoxic treatment allows preservation of large numbers of immature follicles. However, an important concern in patients with leukaemia is the risk of ovarian involvement, and hence possible reintroduction of malignant cells via the graft (Meirow et al, 2008; Dolmans et al, 2010; Rosendahl et al, 2010; Greve et al, 2012; Amiot et al, 2013; Abir et al, 2014) . Indeed, sensitive polymerase chain reaction (PCR) studies have demonstrated that cryopreserved ovarian tissue may harbour leukaemic cells in >50% of cases Rosendahl et al, 2010) and possibly transmit the disease, at least in a xenografting model . In another study where ovarian tissue was taken from leukaemia patients in complete remission, although PCR results were positive in some cases, frozen-thawed ovarian tissue did not appear to contain sufficient numbers of viable malignant cells to transmit the disease when xenografted to mice (Greve et al, 2012) . Nevertheless, given the presence of leukaemic cells and uncertainty of disease transmission, reimplantation of ovarian tissue is not currently recommended in young women cured of acute leukaemia (Dolmans, 2012; Bastings et al, 2013; Dolmans et al, 2013; Rosendahl et al, 2013) .
To avoid this risk in leukaemia patients, one potential fertility-restoring option is grafting of isolated immature follicles in a specially created matrix called a transplantable artificial ovary (Dolmans et al, 2006; Amorim et al, 2009; Vanacker et al, 2011 Vanacker et al, , 2014 Luyckx et al, 2013 Luyckx et al, , 2014 Soares et al, 2015) .
The goal of this study was to evaluate a method of safely isolating follicles and ensuring that suspensions are free of malignant cells from potentially contaminated tissue before grafting back to patients. In a recent publication using a model of ovarian tissue artificially contaminated with a leukaemic cell line (Soares et al, 2015) , we showed that three successive follicle washes were able to eliminate contaminating cells inadvertently retrieved along with follicles, while maintaining good follicle viability. In the present study, the previously described technique was applied to ovarian tissue from leukaemia patients in order to assess the feasibility, efficiency and safety of this follicle isolation technique with a view to clinical application.
For each patient, three subsets were evaluated for the presence of leukaemic cells by PCR using molecular markers of the disease at the time of diagnosis: (i) frozen-thawed ovarian tissue; (ii) isolated follicle suspensions; and (iii) remaining ovarian cell suspensions from which isolated follicles were recovered.
Material and methods

Patients, ovarian tissue cryopreservation and thawing
Use of human ovarian tissue was approved by the Institutional Review Board of the Universit e Catholique de Louvain (IRB, 2012, 125) . Ovarian tissue from 12 leukaemia patients was available for this study: 8 deceased patients and 4 who had donated their tissue for research purposes.
Cryopreservation (slow-freezing) of ovarian tissue was performed between 1999 and 2011, according to our previously described protocol (Amorim et al, 2009) .
In each patient, the specific cytogenetic abnormality or gene rearrangement present in the blood or bone marrow at diagnosis or OTC was investigated. No molecular markers were identified in 2 acute myeloid leukaemia (AML) patients, who were subsequently excluded from this part of the study. Patient characteristics, including age, type of leukaemia and treatment received before OTC, are shown in Table I . One or two cryovials of ovarian tissue per patient were thawed by plunging them into a water bath at 37°C for 2 min. The ovarian fragments were then placed in 3 successive baths of minimal essential medium (MEM)-GlutaMAX at room temperature for 5 min each before processing.
Histology and follicle density
At the time of OTC, a small fragment of ovarian tissue (cortex and medulla) was fixed in 4% formaldehyde and embedded in paraffin. Haematoxylin-eosin-stained slides were analysed for the presence of malignant cells and to determine (Dolmans et al, 2006; Vanacker et al, 2011) . They were subjected to three simple washes immediately after pickup, as previously described (Soares et al, 2015) . This involved manually pipetting and transferring the follicles to fresh droplets of PBS + 10% FBS using a 130 lm micropipette, taking special care to avoid picking up any contaminating cells. This purging step was repeated three times, and the micropipette was regularly replaced.
A few isolated follicles per patient were tested for viability using a calcein AM/ethidium homodimer viability assay (Molecular Probes, Leyden, the Netherlands) as previously reported (Martinez-Madrid et al, 2004) , and examined under a fluorescence microscope (Leica). Based on oocyte and granulosa cell viability, follicles were classified as either V1/ V2, representing follicles with high viability (fully alive or <10% dead granulosa cells), or V3/V4, follicles with poor viability (10-100% dead granulosa cells or a dead oocyte), as detailed in earlier publications by our team (Dolmans et al, 2006) .
Sample storage, nucleic acid extraction and reverse transcription
For Patients 6, 7, 9 and 12, washed isolated follicles were transferred to 350 ll RLT Plus lysis buffer (with 10 ll/ml b-mercaptoethanol (b-ME) and carrier RNA), vortexed thoroughly and stored at À80°C until RNA extraction. For the other patients, whose analyses were to be performed on DNA, washed follicles were transferred to 20 ll PBS, snapfrozen and stored at À80°C until DNA extraction.
Digested ovarian suspensions remaining after follicle pickup were transferred to 1Á5 ml tubes and centrifuged at 240 g for 5 min. For Patients 6, 7, 9 and 10, pellets were resuspended in 600 ll RLT Plus lysis buffer (+b-ME) and transferred to a 10 ml tube. Disruption and homogenization were carried out using the TissueRuptor (IKA T25 digital ULTRA-TURRAX) for 30 s and stored at À80°C before RNA extraction. For the other patients, pellets were snap-frozen and stored at À80°C until DNA extraction.
Nucleic acid extraction was performed using the QIAamp DNA mini kit (catalogue number 56304; QIAGEN, Marseille, France) and RNeasy Plus mini kit for ovarian tissue and digested ovarian suspensions, while for follicles, the QIAamp DNA micro kit and RNeasy Plus micro kit were used according to the manufacturer's recommendations. DNA/RNA yield were determined using a NanoDrop ND-1000 spectrophotometer (NanoDrop, Wilmington, DE). Reverse transcription (RT) was carried out using the Ipsogen â RT kit (Ipsogen, QIAGEN, Marseille, France) as previously described (Soares et al, 2015) on 1 lg of RNA or total RNA (for follicles), to which 15 ll of RT premix was added. The cDNA was used immediately or stored at À80°C.
Polymerase chain reaction
Limits of detection of leukaemic cells among follicle suspensions with the described technique were tested in a preliminary study (Soares et al, 2015) . The detection limit was found to be as low as 2 cells after full sample analysis by both techniques.
Detection of BCR-ABL1 and ETV6-RUNX1 fusion transcripts (Patients 6, 9 and 12). For BCR-ABL1 detection, the BCR-ABL1 major breakpoint cluster region (Mbcr) IS-MMR DX kit (Ipsogen) was used following the manufacturer's instructions. ETV6-RUNX1 was detected using a homemade mix of primers, recommended by the Europe Against Cancer programme (Gabert et al, 2003) . RT-PCR was performed in a final volume of 25 ll, containing 5 ll of cDNA. Each sample and adequate positive and negative controls were amplified at least in duplicate. For follicle suspensions, the entire cDNA sample was tested, as the aim was to exclude leukaemic cell presence. Each amplification curve was defined by its quantification cycle (Cq). 
Risk of disease transmission and blood lymphoblast count
In order to evaluate the potential of disease retransmission through the graft, ovarian tissue from all 12 leukaemia patients initially included in the study was xenografted to severe combined immunodeficient (SCID) mice for 22 weeks. Thawed ovarian tissue fragments were grafted to the inner peritoneum of SCID mice, as previously described . After 6 months, blood (withdrawn by intracardiac puncture) and grafted ovarian tissue were analysed by PCR for leukaemic cell presence. If leukaemic cells found in ovarian tissue are circulating tumour cells, their presence should theoretically be correlated with blood lymphoblast count at the time of OTC. In order to investigate this, blood lymphoblast count was obtained from each patient's medical file just before OTC, and the relationship between lymphoblast count and the presence of leukaemic cells in ovarian tissue was also tested by PCR.
Results
Ovarian tissue histology and follicle density
Follicle density in ovarian tissue, ranging from 0Á38 to 49Á76 follicles/mm² of cortex, is detailed in Table I .
Ovarian tissue examined by two experienced pathologists at the time of OTC showed the presence of leukaemic cells in the ovarian medulla of one patient (Patient 4, Table II ). All the other patients were negative for malignant cell presence at histology.
Follicle isolation and viability
Follicle isolation results are shown in Table I . A total of 3783 follicles were isolated from the 10 patients included in this part of the study, yielding between 30 and 589 washed follicles per patient within 60-90 min. In all cases, isolated follicle density was correlated to follicle density in ovarian tissue, with a mean of 3Á2 (0Á62-5Á25) isolated follicles/mm² of cortical surface area.
One hundred and twenty-six follicles were randomly selected from 8 patients and evaluated for viability using a calcein AM/ethidium homodimer viability assay. In 2 patients (Patients 1 and 5), all the follicles were assigned to 
ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia; CML, chronic myeloid leukaemia; IGH-R, immunoglobulin gene rearrangement; NA, not applicable; OT, ovarian tissue; OTC, ovarian tissue cryopreservation; PCR, polymerase chain reaction. *Leukaemic cells found in the ovarian medulla at the time of OTC.
PCR, as there were not many of them. In order to gain a better overview of the quality and viability of the isolated follicles, numbers of V1-V2 follicles (good-quality follicles) are presented separately for each patient (Table I ). The total good-quality viable follicle rate was 92Á06% (116/126) for follicles retrieved within 90 min of digestion.
PCR analysis
Molecular markers according to disease. All 12 patients included in the study had their bone marrow tested for molecular markers at the time of diagnosis, both to establish their prognosis and ensure satisfactory follow-up of any possible residual disease. Molecular markers identified in patients are presented in Table II . Unfortunately, 3 of the 12 subjects had no molecular markers (Patients 3, 10 and 11). Six patients (Patients 1, 2, 4, 5, 7 and 8) showed FLT3-internal tandem duplication (ITD) or a clonal IGH and TCR gene recombination. The sensitivity of the technique used to detect monoclonal rearrangement or FLT3-ITD was between 10 À2 and 10 À3 .
On the other hand, 3 patients (Patients 6, 9 and 12) presented with reciprocal translocation (BCR-ABL1 or ETV6-RUNX1) evidenced by quantitative RT-PCR (RTqPCR), which is a more sensitive technique. Nevertheless, its sensitivity depends on RNA quality and quantity after extraction. This is reflected by amplification of the housekeeping gene (ABL1 in this case) at the same time as the fusion transcript. Table III shows the quantification results of molecular markers from the 3 patients in whom RTqPCR could be implemented. Numbers of ABL1 gene copies for ovarian tissue and ovarian suspensions are presented, allowing us to calculate and confirm that the sensitivity of the technique for these 3 patients was 10 À5 to 10 À5Á5 for ovarian tissue, and 10 À4 to 10 À4Á5 for ovarian suspensions.
PCR analysis of ovarian tissue and suspensions. All ovarian tissue and digested ovarian suspension samples yielded sufficient amounts of nucleic acids to be tested according to the Europe Against Cancer protocol and European minimal residual disease recommendations (Gabert et al, 2003) . Nucleic acids were not quantified in follicles in order to avoid loss, and whole samples were tested. In this case, housekeeping gene Ct (for RT-PCR) and germline expression (for IGH rearrangement and TCR) served as references.
Results of PCR analysis in all patients for the 3 groups (ovarian tissue, digested ovarian suspensions and isolated follicle suspensions) are shown in Table II . One woman (Patient 3), in whom a monoclonal TRD translocation was identified in a bone marrow sample at diagnosis, showed polyclonal amplification in the same sample when PCR was repeated with currently used primers. PCR was therefore not performed on her ovarian tissue or follicle samples due to the lack of a monoclonal molecular marker. Of the 9 patients tested, six showed leukaemic cell presence in ovarian tissue, with positive PCR in 4/5 acute lymphocytic leukaemia (ALL), 1/1 chronic myeloid leukaemia (CML) and 1/3 AML patients.
In all six patients exhibiting leukaemic cell presence in their ovarian tissue, the same IGH or TCR rearrangement/fusion transcripts were also identified in digested ovarian tissue suspensions from which follicles were retrieved (Table II) . Relative expression of fusion transcripts in ovarian tissue compared to digested tissue suspensions showed 1Á6 to 6Á1-fold higher expression in tissue than in suspensions (Table III) . The 3 patients in whom no malignant cells were detected in ovarian tissue were also negative for malignant cells in ovarian cell suspensions (Table II) .
Having established leukaemic cell presence in the tissue and digested tissue suspensions of 6 out of 9 women, the previously described follicle isolation procedure with 3 washes (Soares et al, 2015) was tested for safe follicle isolation from this contaminated tissue. Entire follicle suspension samples (with up to 14 PCR wells per sample, see Table II) , including more than 2300 follicles in all, were analysed for the presence of leukaemic cells using our established protocol. Evaluating the entire follicle suspension decreases the risk of obtaining false negatives due to small amounts of nucleic acids available for PCR. This allows us to conduct more PCR analyses, thereby increasing the sensitivity of the technique and, consequently, the value of our negative results. None of the 9 patients, even those with positive results in ovarian tissue and digested tissue suspensions, showed any malignant cell presence in isolated follicle suspensions after washing (Fig 1) .
Risk of disease transmission
Results are shown in Table II . Ovarian tissue from 2 ALL patients had previously given rise to diffuse leukaemic masses in mice after 6 months of xenografting (Patients 2 and 3). For the remaining 10 patients tested in this study (4 ALL, 5 AML and 1 CML), although PCR on ovarian tissue was positive for leukaemic cell presence in 5 of the 8 tested, it did not lead to the development of any macroscopic masses after long-term xenografting. PCR analyses performed on grafts recovered from these patients were all negative for leukaemic cell presence, except in one CML patient in whom the BCR-ABL1 fusion gene was detected after 6 months of grafting.
Correlation between minimal disseminated disease and patient blood lymphoblast count at OTC
Blood lymphoblast counts are shown in Table II . We found that a high blood lymphoblast count (>0Á2 9 10 9 /l) at OTC was systematically related to a positive PCR result in ovarian tissue after freeze-thawing. In case of low blast counts (<0Á2 9 10 9 /l), some patients tested positive and others negative. The 2 women (Patients 2 and 3) whose ovarian tissue had produced macroscopic leukaemic masses in mice after xenografting had very high blast counts (>2 9 10 9 /l) at the time of OTC, while another (Patient 12) with a similar blast count did not develop the disease.
Discussion
An important concern when contemplating autotransplantation of cryopreserved ovarian tissue in patients with leukaemia is the risk of re-seeding cancer. Experimental studies by our team and others have shown the presence of leukaemic cells in the cryopreserved ovarian tissue of leukaemia patients by PCR and flow cytometry techniques (Zver et al, 2004 (Zver et al, , 2015 Dolmans et al, 2010; Greve et al, 2012; Jahnukainen et al, 2013) , and the possibility of disease transmission through the graft, at least in a xenografting model . In another study where ovarian tissue was taken from leukaemia patients in complete remission, although PCR results were positive, frozen-thawed ovarian tissue did not appear to contain sufficient numbers of viable malignant cells to transmit the disease when xenografted to mice (Greve et al, 2012) . However, recent flow cytometry studies confirm that at least some of these malignant cells are viable (Zver et al, 2004; Amiot et al, 2013) . Given the presence of leukaemic cells and the uncertainty of disease transmission, reimplantation of ovarian tissue is not currently recommended in young women cured of acute leukaemia (Dolmans, 2012; Bastings et al, 2013; Dolmans et al, 2013; Rosendahl et al, 2013) . To avoid this risk in patients with leukaemia, fertility restoration possibilities include: (i) in vitro culture of follicles followed by in vitro oocyte maturation and in vitro fertilisation (Smitz et al, 2010; Telfer & McLaughlin, 2011; Telfer & Zelinski, 2013) , and (ii) grafting of isolated immature follicles in a specially developed matrix called a transplantable artificial ovary (Dolmans et al, 2006; Amorim et al, 2009; Vanacker et al, 2011 Vanacker et al, , 2014 Luyckx et al, 2013 Luyckx et al, , 2014 .
The main aim of this study was to evaluate our follicle isolation technique to obtain follicle suspensions free of malignant cells from leukaemia patients. Indeed, if these cells are present in ovarian tissue suspensions, they could inadvertently be retrieved along with follicles during the pick-up procedure.
In the present study, a 66% malignant cell contamination rate was observed in cryopreserved ovarian tissue from leukaemia patients, which confirms the high rates observed in previous studies Rosendahl et al, 2010) . Ovarian tissue from 2 of the 6 ALL patients gave rise to leukaemic masses after xenotransplantation, while none of the mice grafted with tissue from the other patients (5 AML and 1 CML) developed any disease.
We showed that, although there seems to be some association between blood blast count and minimal disseminated disease in the ovary in most cases, it cannot be relied upon to accurately predict ovarian involvement. Moreover, while a few rounds of chemotherapy prior to ovarian tissue harvesting appear to decrease/eliminate leukaemic cell presence in ovarian tissue for some patients, this is not the case for all. Indeed, studies by 2 teams have evidenced persistence of leukaemic cells in ovarian tissue (2/12 cases [Zver et al, 2015; ] , 2/4 cases [Greve et al, 2012] ) from leukaemia patients in complete remission using PCR techniques.
When present in ovarian tissue, these leukaemic cells were also systematically detected in ovarian tissue suspensions after enzymatic digestion. However, quantitative analysis in patients expressing specific fusion genes demonstrated higher (up to 6 times) leukaemic cell concentrations in ovarian tissue than in digested suspensions, suggesting loss/destruction of a proportion of these leukaemic cells during the digestion procedure.
For patients at risk of malignant contamination of their ovarian tissue, grafting of follicles isolated from frozenthawed tissue that is free of disease represents one of the options to restore fertility. In the present study, we confirm that it is possible to isolate large numbers of follicles from the cryopreserved ovarian tissue of these patients, while maintaining good follicle viability (92%) even after 90 min of isolation, as previously observed by others using healthy ovarian tissue (Dolmans et al, 2006; Vanacker et al, 2011; Soares et al, 2015) . In a subset of follicles recovered later and tested for viability 4 h post-digestion (data not shown), follicle viability was found to decrease, although not too dramatically (85Á2%), with a greater proportion of extruded oocytes (11Á1% vs. 3Á2% after 90 min), suggesting that increased pick-up time could impact follicle viability.
Our isolation protocol involves 75 min of enzymatic digestion, but was initially set up for digestion of tissue from adult patients. It is nevertheless important to note that during the course of the study, tissue from young patients (<15 years) was found to digest sooner, so the digestion time had to be adjusted to 40-50 min for these young patients. It is helpful that biologists know that ovarian cortex from younger patients is much softer than that of menopausal patients. Tissue hardening with age could be the reason why more time is needed for adult, compared to prepubertal, ovarian cortex digestion.
In a recent publication using a model of ovarian tissue artificially contaminated with a leukaemic cell line, we proved the effectiveness of three successive manual washes of follicle suspensions after pick-up from digested tissue to eliminate contaminating cells inadvertently retrieved along with follicles (Soares et al, 2015) . The primary aim of the present study was to test this technique with naturally invaded ovaries. In this study, we confirm the effectiveness of our isolation technique with 3 washes to obtain disease-free follicle suspensions from ovarian tissue of leukaemia patients. Indeed, follicle suspensions from leukaemia patients (entire RNA and DNA samples) all tested negative for malignant cell presence, even when retrieved from contaminated digested tissue suspensions. Nevertheless, these findings should be interpreted with a degree of caution, as false negatives due to small amounts of nucleic acids cannot be completely ruled out. To circumvent this potential weakness, all available material was analysed and up to 14 PCRs were performed per patient to ensure that our results were as accurate as possible.
Having shown that modern PCR techniques are sensitive enough to detect as few as 2 leukaemic cells among follicles, these results are very encouraging and suggest the absence of contamination of isolated follicle suspensions, or at least levels below the detection limit (<2 cells).
In conclusion, we show that our follicle isolation technique allows recovery of a large proportion of follicles present in ovarian tissue from leukaemia patients. Suspensions of recovered isolated follicles all tested negative for the presence of leukaemic cells, which is very reassuring given that our technique allows detection of as few as 2 cells in follicle suspensions. Moreover, these follicles exhibit good viability that decreases moderately with isolation time. When leukaemic cells are detected in ovarian tissue, they are also present in digested ovarian tissue suspensions, but at lower concentrations. Furthermore, a low blood blast count at the time of OTC does not exclude ovarian involvement. Our study includes ovarian tissue from 12 leukaemia patients. Relatively small patient numbers are inevitable because only material from leukaemia patients who have died or donated their ovarian tissue to research (having already given birth and no longer needing this tissue) can be used, and these 2 conditions are relatively infrequent. Our results nevertheless represent an exciting new approach for leukaemia patients, but need to be confirmed by a multicentre study.
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